Arrhenatherum elatius
Arrhenatherum elatius · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Arrhenatherum elatius, commonly known as false oat-grass, is a perennial grass frequently found in various meadow and wasteland habitats. This species is characterized by its tall, upright growth habit and distinctive slender foliage. Within its biological makeup, the plant's leaves serve as a primary part for study and analysis. Chemical investigations of the species have identified important compounds such as cynaroside and thermopsoside. Understanding these specific elements provides valuable insight into the complex chemical profile of this widespread grass.
- Synonyms
- Avena Elatior · Avenastrum Elatius · 1 more
- Common names
- Not available
- Family
- Poaceae
- Distribution
- Asia-Temperate
- Plant Parts
- Leaf
Classification
Common Names
Arrhenatherum elatius is a versatile grass species known by a diverse array of regional and linguistic identifiers. In English-speaking regions, it is most commonly referred to as False Oat-Grass. Its nomenclature shifts across Europe, appearing as Almindelig draphavre or simply Draphavre in certain Scandinavian contexts. German speakers identify the plant as Franzoesisches Raygras, while Welsh speakers use the name Ceirchwellt Tal. These varied names highlight the plant's widespread presence and cultural significance across different territories.
Sources: Catalogue of Life (COL)
Synonyms
Arrhenatherum elatius is a grass species that has been identified by several different scientific names throughout botanical history. Due to various taxonomic classifications, it is recognized by the synonym Avena elatior in certain contexts. Researchers also frequently refer to the plant as Avenastrum elatius when discussing its lineage. Furthermore, the name Holcus elatior has been used as a synonym, reflecting the complexity of its botanical categorization. Understanding these multiple designations is essential for accurately identifying the species across different scientific records.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Arrhenatherum elatius is a distinctive member of the kingdom Plantae. This plant belongs to the class Equisetopsida and is categorized under the order Poales. Within this botanical framework, it is classified under the family Poaceae. It further falls into the specific genus Arrhenatherum. Such a clear taxonomic hierarchy helps researchers understand its unique position in the natural world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Poales |
| Family | Poaceae |
| Genus | Arrhenatherum |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Arrhenatherum elatius maintains a widespread presence across several diverse geographical regions. Its primary distribution spans much of Africa, with a specific concentration found throughout Northern Africa in countries like Algeria and Morocco. The plant also thrives within the Macaronesia archipelago, establishing itself across various island territories. This includes notable populations in the Azores, the Canary Islands, and Madeira. Consequently, this species demonstrates a significant ecological footprint across both mainland Africa and its surrounding Atlantic islands.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Arrhenatherum elatius is a self-supporting herb characterized by its sturdy and upright growth form. This plant typically reaches a height ranging from a minimum of 0.5 meters to a maximum of 1.5 meters. While it can be found at various stages of development, many specimens commonly reach heights exceeding 1.19 meters. Its structural integrity allows it to stand firmly within its natural habitat without external support. Overall, these dimensions define the physical presence of this versatile herbaceous species.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Arrhenatherum elatius is a problematic weed that possesses significant medicinal potential due to its unique chemical composition. Recent computational studies have identified that this plant contains the important compounds Cynaroside and Thermopsoside within its leaves. Molecular docking simulations revealed that both of these substances exhibit strong binding affinities toward metallo-beta-lactamase enzymes. Furthermore, molecular dynamics trajectories confirmed that Cynaroside and Thermopsoside maintain stable conformations when interacting with these bacterial targets. These findings suggest that the components found in Arrhenatherum elatius could serve as effective competitive inhibitors to combat antimicrobial resistance.
Conditions
Arrhenatherum elatius contains compounds that serve as potential inhibitors for Metallo-beta-lactamase (MBL) enzymes. Specifically, bioactive molecules such as Cynaroside and Thermopsoside extracted from its leaves demonstrate a strong binding affinity to these enzymes. By effectively targeting MBL enzymes, these plant-derived components help address the critical issue of antimicrobial resistance. This mechanism is significant because MBL-mediated resistance poses a global threat to existing antimicrobial chemotherapies. Therefore, utilizing Arrhenatherum elatius offers a promising computational pathway for developing new drugs to combat resistant bacterial strains.
Preparations
Parts used
Arrhenatherum elatius is a problematic weed that is increasingly being recognized for its significant medicinal properties. Recent computational studies have specifically focused on exploring the chemical potential found within its leaves. Researchers utilized bioinformatics to identify compounds that could serve as effective inhibitors against metallo-beta-lactamase enzymes. The analysis revealed that specific constituents, such as Cynaroside and Thermopsoside, exhibit strong binding affinities to these enzymes. These findings suggest that the leaf extracts of this plant could play a vital role in developing new treatments to combat antimicrobial resistance.